A new study shows dopamine isn’t the brain’s movement “gas pedal” after all. Instead of setting speed or strength, it quietly ...

Parkinson’s disease currently affects nearly one million Americans with no specific known cause and no cure. Treatments have come a long way over the past few decades focusing on managing symptoms and ...

A 67-year-old says a new £2,000 device, which is being studied by the NHS, has improved his sleep and allowed him to go back ...

A research team led by McGill University has taken a close look at a long-standing idea about Parkinson’s disease and found ...

Explore dopamine's role in movement and how it challenges long-standing theories about motor control and Parkinson's disease ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY GOTHENBURG, NE / ACCESS Newswire / December 23, 2025 / IRLAB Therapeutics AB (Nasdaq Stockholm: IRLAB A ...

A new study from McGill University challenges a decades-old belief about dopamine. Rather than driving movement like a ...

Obstructive sleep apnea (OSA) may be associated with an increased risk of developing Parkinson disease, although early treatment with continuous positive airway pressure (CPAP) could help mitigate ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

People with restless leg syndrome may also have a higher risk for Parkinson's disease, a study from the Republic of Korea has found.

A McGill-led study is challenging a popular theory about how dopamine drives movement, a discovery that could shift how ...